High circulating levels of adiponectin are related to a reduced risk of developing endometrial cancer, independent of the other risk factors such as insulin resistance and hypothyroidism that cause obesity [189]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.